143 related articles for article (PubMed ID: 11813096)
1. Update on the botulinum neurotoxins.
Carruthers A; Carruthers J
Skin Therapy Lett; 2001 Dec; 6(13):1-2. PubMed ID: 11813096
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin-B and the management of hyperhidrosis.
Baumann LS; Halem ML
Clin Dermatol; 2004; 22(1):60-5. PubMed ID: 15158547
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin in cervical dystonia.
Tsui JK; Calne DB
Adv Neurol; 1988; 49():473-8. PubMed ID: 3344637
[No Abstract] [Full Text] [Related]
4. [Botulinum toxin. Development for therapeutic purposes].
Ceballos-Baumann A
Nervenarzt; 2008 Jun; 79 Suppl 1():3-8. PubMed ID: 18927957
[TBL] [Abstract][Full Text] [Related]
5. Review of the use of botulinum toxin for hyperhidrosis and cosmetic purposes.
Glogau RG
Clin J Pain; 2002; 18(6 Suppl):S191-7. PubMed ID: 12569968
[TBL] [Abstract][Full Text] [Related]
6. Quantitative electromyographical changes in cervical dystonia after treatment with botulinum toxin.
Fuglsang-Frederiksen A; Ostergaard L; Sjö O; Werdelin L; Winkel H
Electromyogr Clin Neurophysiol; 1998 Mar; 38(2):75-9. PubMed ID: 9553744
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type B: a new injectable treatment for cervical dystonia.
Brashear A
Expert Opin Investig Drugs; 2001 Dec; 10(12):2191-9. PubMed ID: 11772315
[TBL] [Abstract][Full Text] [Related]
8. Expanding use of botulinum toxin.
Bhidayasiri R; Truong DD
J Neurol Sci; 2005 Aug; 235(1-2):1-9. PubMed ID: 15990116
[TBL] [Abstract][Full Text] [Related]
9. Cervical dystonia and botulinum treatment: is electromyographic guidance necessary?
Speelman JD; Brans JW
Mov Disord; 1995 Nov; 10(6):802. PubMed ID: 8750005
[No Abstract] [Full Text] [Related]
10. Handling botulinum toxins: an updated literature review.
Trindade De Almeida AR; Secco LC; Carruthers A
Dermatol Surg; 2011 Nov; 37(11):1553-65. PubMed ID: 21777338
[TBL] [Abstract][Full Text] [Related]
11. [Clinical use of botulinum toxin].
Jost WH
Nervenarzt; 2008 Jun; 79 Suppl 1():9-14. PubMed ID: 18927958
[TBL] [Abstract][Full Text] [Related]
12. Development of botulinum toxin therapy.
Hermanowicz N; Truong DD
West J Med; 1995 Nov; 163(5):472-3. PubMed ID: 8533413
[No Abstract] [Full Text] [Related]
13. New therapeutic indications for botulinum toxins.
Cordivari C; Misra VP; Catania S; Lees AJ
Mov Disord; 2004 Mar; 19 Suppl 8():S157-61. PubMed ID: 15027069
[TBL] [Abstract][Full Text] [Related]
14. The botulinum toxins in the treatment of cervical dystonia.
Brashear A
Semin Neurol; 2001; 21(1):85-90. PubMed ID: 11346029
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin type B for glabellar wrinkles: a prospective open-label response study.
Sadick NS; Faacs
Dermatol Surg; 2002 Sep; 28(9):817-21. PubMed ID: 12269875
[TBL] [Abstract][Full Text] [Related]
16. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
17. Smile--you're on botox!
Corliss R
Time; 2002 Feb; 159(7):59. PubMed ID: 11881439
[No Abstract] [Full Text] [Related]
18. [Botulinum toxin injection techniques in the lower third and middle of the face, the neck and the décolleté: the "Nefertiti lift"].
Gassia V; Beylot C; Béchaux S; Michaud T
Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S111-8. PubMed ID: 19576476
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin A: a review of 1,085 oral and maxillofacial patient treatments.
Niamtu J
J Oral Maxillofac Surg; 2003 Mar; 61(3):317-24. PubMed ID: 12618971
[TBL] [Abstract][Full Text] [Related]
20. FDA Approvals and Consensus Guidelines for Botulinum Toxins in the Treatment of Dystonia.
Spiegel LL; Ostrem JL; Bledsoe IO
Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32429600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
